We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu
IMPORTANT: Due to the lapse in government funding, the information on this web site may not be up to date, transactions submitted via the web site may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

Shared Decision Making for Schizophrenia

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00220870
Recruitment Status : Completed
First Posted : September 22, 2005
Last Update Posted : April 8, 2010
Sponsor:
Information provided by:

Study Description
Brief Summary:
The impact of a decision aid for inpatients with schizophrenia on perceived involvement and compliance is studied in comparison with routine care.

Condition or disease Intervention/treatment
Schizophrenia Behavioral: Decision aid

Detailed Description:
to follow

Study Design

Study Type : Interventional  (Clinical Trial)
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Prevention
Official Title: Shared Decision Making in the Therapy of Schizophrenia
Study Start Date : January 2003
Estimated Study Completion Date : August 2005

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Schizophrenia
U.S. FDA Resources

Arms and Interventions


Outcome Measures

Primary Outcome Measures :
  1. Patients' compliance

Secondary Outcome Measures :
  1. perceived involvement in medical decisions
  2. rehospitalizations
  3. QoL

Eligibility Criteria

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 65 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • schizophrenia (ICD10)
  • age 18 - 65 years
  • inpatients

Exclusion Criteria:

  • mental retardation
  • no informed consent
Contacts and Locations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00220870


Locations
Germany
Psychiatric Department, TU München
München, Germany, 81675
Sponsors and Collaborators
Technische Universität München
Investigators
Study Chair: Werner Kissling, MD TU München, Psychiatric Department
More Information

Additional Information:
ClinicalTrials.gov Identifier: NCT00220870     History of Changes
Other Study ID Numbers: 217-43794-5/9
First Posted: September 22, 2005    Key Record Dates
Last Update Posted: April 8, 2010
Last Verified: April 2010

Keywords provided by Technische Universität München:
schizophrenia
shared decision making
compliance
maintenance therapy

Additional relevant MeSH terms:
Schizophrenia
Schizophrenia Spectrum and Other Psychotic Disorders
Mental Disorders